Skip to main content
. Author manuscript; available in PMC: 2021 Jun 28.
Published in final edited form as: Nat Genet. 2021 Feb 8;53(3):342–353. doi: 10.1038/s41588-020-00774-y

Extended Data Fig. 2.

Extended Data Fig. 2

Survival analyses of p53-SRSF1 PPI perturbing-mutations and p53 mutations alone. Three exemplary cancer types, including bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), and colon adenocarcinoma (COAD), are illustrated. Survival analyses of p53-SRSF1 PPI perturbing-mutations across other cancer types/subtypes are provided in Supplementary Fig. 14. The p-value (P) was computed by log-rank test. All oncoPPI-predicted survival analyses for 33 cancer types/subtypes are freely available at the following website: https://mutanome.lerner.ccf.org/.